Ductal Carcinoma in Situ of the Breast
June 2017 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Ductal Carcinoma in Situ of the Breast. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Ductal Carcinoma in Situ of the Breast. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Ductal Carcinoma in Situ of the Breast every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:DCIS and axillary nodal evaluation: compliance with national guidelines.
Authors:Mitchell KB, Lin H, Shen Y, Colfry A, Kuerer H, Shaitelman SF, Babiera GV, Bedrosian I
Institution:Department of Breast Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, 77030, USA. Houston, TX, USA. Houston, TX, USA. Center, Houston, TX, 77030, USA. Center, Houston, TX, 77030, USA. Houston, TX, USA. Center, Houston, TX, 77030, USA.
Journal:BMC Surg. 2017 Feb 7;17(1):12. doi: 10.1186/s12893-017-0210-5.

2:Aesthetic and functional outcome after breast conserving surgery - Comparison between conventional and oncoplastic resection.
Authors:Ojala K, Meretoja TJ, Leidenius MH
Institution:Breast Surgery Unit, Comprehensive Cancer Center, Helsinki University Hospital and Helsinki University, Finland. Electronic address: kaisu.ojala@helsinki.fi. and Helsinki University, Finland. and Helsinki University, Finland.
Journal:Eur J Surg Oncol. 2017 Apr;43(4):658-664. doi: 10.1016/j.ejso.2016.11.019. Epub 2016 Dec 18.

3:Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Authors:Langhans L, Jensen MB, Talman MM, Vejborg I, Kroman N, Tvedskov TF
Institution:Department of Plastic Surgery, Breast Surgery and Burns, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. Copenhagen, Denmark. Denmark. Denmark. University of Copenhagen, Copenhagen, Denmark. University of Copenhagen, Copenhagen, Denmark.
Journal:JAMA Surg. 2017 Apr 1;152(4):378-384. doi: 10.1001/jamasurg.2016.4751.

4:No impact of breast magnetic resonance imaging on 15-year outcomes in patients with ductal carcinoma in situ or early-stage invasive breast cancer managed with breast conservation therapy.
Authors:Vapiwala N, Hwang WT, Kushner CJ, Schnall MD, Freedman GM, Solin LJ
Institution:Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. Philadelphia, Pennsylvania. Pennsylvania. Pennsylvania. Philadelphia, Pennsylvania.
Journal:Cancer. 2017 Apr 15;123(8):1324-1332. doi: 10.1002/cncr.30479. Epub 2016 Dec 16.

5:Hypofractionation Is an Acceptable Alternative to Conventional Fractionation in the Treatment of Postlumpectomy Ductal Carcinoma In Situ With Radiotherapy.
Authors:Isfahanian N, Al-Hajri T, Marginean H, Chang L, Caudrelier JM
Institution:Department of Radiation Medicine, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada. Ontario, Canada. Ontario, Canada. Ontario, Canada. Electronic address: jcaudrelier@toh.ca.
Journal:Clin Breast Cancer. 2017 Apr;17(2):e77-e85. doi: 10.1016/j.clbc.2016.10.005. Epub 2016 Oct 19.

6:Identifying progression predictors of breast ductal carcinoma in situ.
Authors:Yeong J, Thike AA, Tan PH, Iqbal J
Institution:Division of Pathology, Singapore General Hospital, Singapore, Singapore. (A*STAR), Singapore, Singapore.
Journal:J Clin Pathol. 2017 Feb;70(2):102-108. doi: 10.1136/jclinpath-2016-204154. Epub 2016 Nov 18.

7:Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.
Authors:El Hage Chehade H, Headon H, Wazir U, Abtar H, Kasem A, Mokbel K
Institution:The London Breast Institute, Princess Grace Hospital, 42-52 Nottingham Place, London W1U 5NY, UK. Electronic address: haj_shehadeh_hiba@hotmail.com. London W1U 5NY, UK. London W1U 5NY, UK. London W1U 5NY, UK. London W1U 5NY, UK. London W1U 5NY, UK.
Journal:Am J Surg. 2017 Jan;213(1):171-180. doi: 10.1016/j.amjsurg.2016.04.019. Epub 2016 Sep 6.

8:Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Authors:Groen EJ, Elshof LE, Visser LL, Rutgers EJ, Winter-Warnars HA, Lips EH, Wesseling J
Institution:Department of Pathology, Division of Diagnostic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Institute-Antoni van Leeuwenhoek Hospital, The Netherlands. Leeuwenhoek Hospital, The Netherlands. Institute-Antoni van Leeuwenhoek Hospital, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, The Netherlands. Electronic address: j.wesseling@nki.nl.
Journal:Breast. 2017 Feb;31:274-283. doi: 10.1016/j.breast.2016.09.001. Epub 2016 Sep 23.

9:Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation.
Authors:Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag D
Institution:Department of Radiation Therapy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. School, Boston, Massachusetts. School, Boston, Massachusetts. Health Care Institute, Boston, Massachusetts. of Wisconsin School of Medicine, Madison. Institute, Boston, Massachusetts. School, Boston, Massachusetts.
Journal:JAMA Oncol. 2017 Jan 1;3(1):101-104. doi: 10.1001/jamaoncol.2016.2164.

10:Prediction of invasive breast cancer using shear-wave elastography in patients with biopsy-confirmed ductal carcinoma in situ.
Authors:Bae JS, Chang JM, Lee SH, Shin SU, Moon WK
Institution:Department of Radiology, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, 110-744, Korea. Jongno-gu, Seoul, 110-744, Korea. imchangjm@gmail.com. Jongno-gu, Seoul, 110-744, Korea. Jongno-gu, Seoul, 110-744, Korea. Jongno-gu, Seoul, 110-744, Korea.
Journal:Eur Radiol. 2017 Jan;27(1):7-15. Epub 2016 Apr 16.

For a FREE PREVIEW of the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast...
at a Special 20% Discount


Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast

Updated: January 29, 2017
144 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Ductal Carcinoma in Situ of the Breast is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

DC32489062

Coupon Expires: July 22, 2017



What Our Customers Are Saying...

"The MediFocus Guidebook on DCIS was more than adequate for my research on this condition and I would recommend it to anyone wanting the "whole picture". Thank you for providing this excellent service."
C.M.
Los Angeles, California


"At a very difficult time, your MediFocus Guidebook on Ductal Carcinoma in Situ helped our family make informed decisions. Thank you for your help!"
M.A.L.
Metarie, Louisiana


"I was recently diagnosed with DCIS and was looking everywhere for information to get myself educated. The MediFocus Guidebook was very helpful in clarifying everything for me. The information is so well organized that it makes it easy to read and understand. I feel much better now that I've read this Guidebook and have a clearer understanding of the issues that I face. I highly recommend this Guidebook to anyone seeking to understand DCIS."
C.G.
Ft. Lauderdale, Florida



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.